As pathogenic bacteria evolve, antibiotic resistance is spreading, compromising our ability to control and treat infectious diseases. Antibiotic Resistance thoroughly illuminates this crucial issue for healthcare professionals, researchers, students, and policymakers. Two leading investigators explain what resistance is, how it emerges, which human activities contribute, and how to strengthen our defenses.
About the Author, Karl Drlica
Karl Drlica, Ph.D. is a Principal Investigator at the Public Health Research Institute and Professor of Microbiology & Molecular Genetics at the UMDNJ–New Jersey Medical School in Newark, NJ. His laboratory focuses on fluoroquinolone action and resistance with Mycobacteriun tuberculosis and other bacteria, including approaches for slowing the enrichment and amplification of resistant bacterial subpopulations.
David S. Perlin, Ph.D. is Executive Director of the Public Health Research Institute and UMDNJ Regional Biocontainment Laboratory, as well as Professor of Microbiology & Molecular Genetics at the New Jersey Medical School in Newark, NJ. He is also a Fellow of the New York Academy of Sciences. Dr. Perlin’s laboratory explores mechanisms of antifungal drug resistance, rapid detection of drug resistant bloodstream pathogens in high-risk patients, and the application of small-animal models for the study of respiratory pathogens.
